Elevation Oncology Inc (ELEV)

$3.61 0.00 (0.00%)

16:00 EDT ELEV Stock Quote Delayed 30 Minutes

ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024

By InvestorPlace Earnings May 2, 2024

ELEV stock results show that Elevation Oncology missed analyst estimates for earnings per share the first quarter of 2024.

7 Top Stocks Under $7

ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023

Trim the Fat: 3 Overbought Stocks Poised for a Pullback

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 173,129

Day's Range $3.50 - $3.67

52-Week Range $0.36 - $5.89

Dividend & Yield N/A (N/A)

ELEV Stock Predictions, Articles, and Elevation Oncology Inc News

From InvestorPlace
From the Web

3 Stock Winners That Are Up 400% or More in 2024

By Shane Neagle, InvestorPlace Contributor Feb 23, 2024

Explore stocks winners of 2024, including MicroCloud, Beamr Imaging, and Elevation Oncology, each seeing 400% gains in a GenAI-led rally.

Why Is Elevation Oncology (ELEV) Stock Down 26% Today?

By William White, InvestorPlace Writer Jun 9, 2023

Elevation Oncology (ELEV) stock is taking a beating on Friday after the healthcare company announced a public stock offering.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jun 9, 2023

It's time for a final look at the biggest pre-market stock movers this week as we check out what's happening on Friday morning!

Why Is Elevation Oncology (ELEV) Stock Up 57% Today?

By William White, InvestorPlace Writer May 26, 2023

Elevation Oncology (ELEV) stock is on the rise Friday with heavy trading despite a lack of news from the pharmaceutical company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer May 26, 2023

It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!

Elevation Oncology gets new CEO and promotes to CFO (NASDAQ:ELEV)

From Seeking Alpha Jul 13, 2023

Innovative oncology company Elevation Oncology (ELEV), appoints Joseph Ferra as its CEO. Mr. Ferra was previously interim CEO and CFO. Mr

Elevation Oncology slumps 25%, prices $50M public offering

From Seeking Alpha Jun 9, 2023

Innovative oncology company, Elevation Oncology (ELEV) stock drops 25% as it proposes public offering of stock and warrants.The company prices 17.81M shares and pre-funded warrants...

Steve Cohen's Point72 Disclosed 8.7% Stake In Elevation Oncology

From MarketBeat May 30, 2023

Shares of ELEV have risen 428% YTD. Will the stock continue to perform with a critical upcoming catalyst on the horizon?

How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?

From MarketBeat Jan 25, 2023

Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate.

Elevation Oncology CEO resigns as part of company prioritization effort (NASDAQ:ELEV)

From Seeking Alpha Jan 6, 2023

Elevation Oncology (ELEV) CEO Shawn Leland has resigned amid a company effort to realign resources and prioritize pipeline assets.

J.P. Morgan downgrades Elevation Oncology (ELEV) to a Sell

From TipRanks Nov 14, 2022

Elevation Oncology (ELEV – Research Report) received a Sell rating and price target from J.P. Morgan analyst Anupam Rama yesterday. The company’s shares...

ADVERTISEMENT